Association of plasma nitric oxide concentration and endothelial nitric oxide synthase T-786C gene polymorphism in coronary artery disease

Pathophysiology

Volumn 19, Issue 3, 2012, Pages 157-162

  Salimi, Saeedeh ^a,b   Naghavi, Anoosh ^a   Firoozrai, Mohsen ^c   Zand, Hamid ^d   Tavilani, Heidar ^e   Nakhaee, Alireza ^a,b   Mohebbi, Ahmad ^f  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coronary artery disease; Nitric oxide; Nitric oxide synthase gene; Polymorphism

Indexed keywords

CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; TRIACYLGLYCEROL;

ADULT; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; ENOS GENE; ETHNIC GROUP; FAMILY HISTORY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IRANIAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; NOS GENE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SYMPTOMATOLOGY; SYSTOLIC BLOOD PRESSURE;

EID: 84865420029     PISSN: 09284680     EISSN: 1873149X     Source Type: Journal    
DOI: 10.1016/j.pathophys.2012.04.003     Document Type: Article

References (29)

1. Moncada S., Palmer R.M., Higgs E.A. Nitric Oxide: physiology, pathophysiology, and pharmacology. Pharmacological Research 1991, 43:109-142.
2. Wang Y., Marsden P.A. Nitric oxide synthase: biochemical and molecular regulation. Current Opinion in Nephrology and Hypertension 1995, 4:12-22.
3. Waldman S.A., Muard F. Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cyclic GMP system. Journal of Cardiovascular Pharmacology 1988, 12(Suppl 5):15-18.
4. Marsden P.A., Heng H.H., Scherer S.W., Stewart R.J., Hall A.V., Shi X.M., Tsui L.-C., Schappert K.T. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. Journal of Biological Chemistry 1993, 268:17478-17488.
5. Nadaud S., Bonnardeaux A., Lathrop M., Soubrier F. Gene structure polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochemical and Biophysical Research Communication 1994, 198:1027-1033.
6. Yoon S., Moon J., Shin Ch, Kim E., Jo S.A., Jo I. Smoking status-dependent association of the 27-bp repeat polymorphism in intron4 of endothelial nitric oxide synthase gene with plasma nitric oxide concentrations. Clinica Chimica Acta 2002, 324:113-120.
7. Hingorani A.D. Polymorphisms of endothelial nitric oxide synthase and atherogenesis. Atherosclerosis 2000, 154:521-527.
8. Kone B.C. Molecular biology of natriuretic peptides and nitric oxide synthase. Cardiovascular Research 2001, 51:29-441.
9. Yoshimura M., Yasue H., Nakayama M., et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spam in the Japanese. Human Genetics 1998, 103:65-69.
10. Yoshimura M., Yasue H., Nakayama M., Shimasaki Y., Kujiyama K., Ogawa H., Motoyama T., Saito Y., Ogawa Y., Miamoto Y. Genetic risk factors for coronary artery spasm: significance of endothelial nitric oxide synthase gene T-786→C and missense Glu298Asp variants. Journal of Investigative Medicine 2000, 48:367-374.
11. Nakayama M., Yasue H., Yoshimura M., Shimasaki Y., Kujiyama K., Ogawa H., Motoyama T., Saito Y., Ogawa Y., Miamoto Y. T786C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999, 99:2864-3287.
12. Stangl K., Cascorbi I., Laule M., High CA repeat numbers in intron 13 of the endothelial nitric oxide synthase gene and increased risk of coronary artery disease. Pharmacogenetics 2000, 10:133-140.
13. Yoon Y., Song J., Hong S.H., Kim J.Q. Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clinical Chemistry 2000, 46:1626-1630.
14. Wang X.L., Mahaney M.C., Sim A.S., Wang J., Wang J., Blangero J., Almasy L., Badenhop R.B., Wilcken D. Genetic contribution of endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arteriosclerosis, Thrombosis and Vascular Biology 1997, 17:3147-3153.
15. Tsukada T., Yokoyama K., Arai T., Takemoto F., Hara S., Yamada A., Kawaguchi Y., Hosoya T., Igari J. Evidence of association of ecNOS gene polymorphism with plasma NO metabolic levels in humans. Biochemical and Biophysical Research Communications 1998, 245:190-193.
16. Salimi S., Firoozrai M., Nourmohammadi I., Shabani M., Shafiee S.M., Mohebbi A., Tavilani H. Lack of evidence for contribution of intron4a/b polymorphism of endothelial nitric oxide synthase (NOS3) gene to plasma nitric oxide levels. Acta Cardiologica 2008, 63:229-234.
17. 15N] nitrate in biological fluids. Analytical Biochemistry 1982, 126:131-138.
18. Wang X.L., Sim A.S., Badenhop R.F., McCredie R.M., Wilcken D.E. A smoking-dependent risk of coronaryartery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nature Medicine 1996, 2:41-45.
19. Umbach D.M., Weinberg C.R. Designing and analyzing case-control studies to exploit independence of genotype and exposure. Statistics in Medicine 1997, 16:1731-1743.
20. Loscalzo J., Welch G. Nitric oxide and its role in cardiovascular system. Progress in Cardiovascular Diseases 1995, 38:87-104.
21. Sim A.S., Wang J., Wilcken D., Wang X.L. MspI polymorphism in the promoter of the human endothelial constitutive NO synthase gene in Australian Caucasian population. Molecular Genetics and Metabolism 1998, 65:62-66.
22. Ghilardi G., Biondi M.L., DeMonti M., Bernini M., Turri O., Massaro F., Guagnellini E., Scorza R. Independent risk factor for moderat to severe internal carotid artery stNOS3is: T786C mutation of the endothelial nitric oxide synthase gene. Clinical Chemistry 2002, 48:989-993.
23. Erbs S., Baither Y., Linke A., Adams V., Shu Y., Lenk K., Gielen S., Dilz R., Schuler G., Hambrecht R. Promoter but not exon 7 polymorphism of endothelial nitric oxide synthase affects training-induced correction of endothelial dysfunction. Arteriosclerosis, Thrombosis, and Vascular Biology 2003, 23:1814-1819.
24. Tangurek B., Ozer N., Sayar N., Terzi S., Yilmaz H., Dayi S.U., Ciloglu F., Aksu H., Asilturk R., Cagil A. The relationship between endothelial nitric oxide synthase gene polymorphism (T-786C) and coronary artery disease in the Turkish population. Heart and Vessels 2006, 21:285-290.
25. Kim I.J., Bae J., Lim S.W., Cha D.H., Cho H.J., Kim S., Yang D.H., Hwang S.G., Oh D., Kim N.K. Influence of endothelial nitric oxide synthase gene polymorphisms (-786T>C, 4a4b, 894G>T) in Korean patients with coronary artery disease. Thrombosis Research 2007, 119:579-585.
26. Jaramillo P.C., Munoz M.A., Lanas M.C., Lanas Z.F., Salazar L. A. Endothelial nitric oxide synthase G894T gene polymorphism in Chilean subjects with coronary artery disease and controls. Clinica Chimica Acta 2006, 371:102-109.
27. Moon J., Yoon S., Kim E., Shin C., Jo S., Jo I. Lack of evidence for contribution of Glu298Asp (G894T) polymorphism of endothelial nitric oxide synthase gene to plasma nitric oxide levels. Thrombosis Research 2002, 107:129-134.
28. Li R., Lyn D., Lapu-Bula R., Oduwole A., Igho-Pemu P., Lankford B., Morgan J., Nkemdechi S., Liu G., Pack C., Silvestrov N., von Deutsch D.A., Song Q., Abukhalaf I.K., Ofili E. Relation of endothelial nitric oxide synthase gene to plasma nitric oxide level, endothelial function, and blood pressure in African Americans. American Journal of Hypertension 2004, (July):560-567.
29. Nagassaki S., Metzger I.F., Souza-Costa D.C., Marroni A.S., Uzuelli J.A., Tanus-Santos J.E. NOS3 genotype is without effect on circulating nitrite/nitrate level in healthy male population. Thrombosis Research 2005, 115:375-379.